Polaris Market Research Releases Synthetic Biology Market Outlook 2026-2034: AI and Agri-Biotech Lead Growth
New industry analysis projects a USD 73.62 Billion synthetic biology market by 2034 as engineered crop development, precision medicine adoption, and automation-driven biomanufacturing reshape industry expansion.
| Market Size 2025 | Forecast 2034 | CAGR 2026-2034 | Leading Region |
| USD 17.96 Billion | USD 73.62 billion | 16.97% | North America (42.10%) |
Source: Polaris Market Research Analysis
Polaris Market Research & Consulting has released its Synthetic Biology Market Report 2026-2034. The market was estimated to be worth USD 17.96 billion in 2025 and is expected to grow to USD 73.62 billion by 2034 at a CAGR of 16.97%. The growth is propelled by the rising use of precision medicines, the application of agriculture biotechnology, and growing investments in biological automation.
The recent trends in the market include the rising commercial activities in the market. For example, in January 2026, Twist Bioscience indicated that its preliminary revenue for Q4 2025 grew by 17%, which included a rise in revenues from DNA synthesis and protein solutions by 27%. In March 2026, GenScript unveiled plans for building a European mRNA hub, further developing its regional biotech presence. In April 2026, GenScript and Mimulus formed a collaboration to develop DNA data storage solutions.
“With the help of agricultural biotechnology, automated laboratory platforms, and the ability to synthesize DNA, synthetic biology is becoming a scalable infrastructure market in terms of commercialization. Organizations with experience in biological engineering, automation, regulatory compliance, and manufacturing will have a competitive advantage as industry adoption increases.” — Prajakta Bengale, Research Manager
Synthetic Biology Market Investment Signals 2026
| Investment Theme | Market Signal | Business Implication |
| DNA Synthesis Infrastructure | Expansion of long-DNA and gene synthesis capacity | Supports commercialization at scale |
| Biomanufacturing Expansion | Rising investment in advanced production facilities | Strengthens supply chain capabilities |
| Laboratory Automation | Rising bio foundry investments | Improves operational efficiency |
| Compliance & Screening | Stronger biosecurity requirements | Supports premium platform adoption |
Source: Polaris Market Research Analysis
Three Market Developments Reshaping the Synthetic Biology Industry in 2026
Agricultural Applications Are Becoming a Major Commercial Opportunity
Synthetic biology is increasingly being applied to agricultural biotechnology through the development of engineered crops with enhanced productivity, pest resistance, and climate adaptability. Growing global concerns regarding food security and sustainable agriculture are increasing investment in advanced crop engineering technologies.
Automation Is Improving Biological Development Efficiency
Laboratory automation and AI-enabled design platforms are reducing development timelines across synthetic biology workflows. Automated bio foundries allow researchers to rapidly test and optimize biological systems at scale. Organizations investing in automation infrastructure are improving productivity while reducing operational complexity.
DNA Infrastructure Is Expanding Beyond Traditional Research Markets
The emergence of applications such as DNA-based data storage, advanced biologics manufacturing, and engineered biological materials is expanding the addressable market for synthetic biology technologies.
About the Polaris Synthetic Biology Market Report 2026-2034
The report covers market sizing, segmentation, regional analysis, competitive landscape, and technology assessment across the synthetic biology value chain. It is designed for biotechnology companies, pharmaceutical organizations, investors, government agencies, and industrial biotechnology developers seeking strategic insights into market opportunities, innovation trends, and competitive positioning.
Report coverage: Market size and CAGR by product, technology, application, and end user | Regional analysis across 5 regions with country-level breakdowns | 12 company profiles with financial benchmarking | Regulatory environment heatmap by country | Technology and innovation landscape | PDF and Excel formats | Customization available by country, region, and segment
Request a free sample copy or read the full market insights : Synthetic Biology Market Report
Key Companies Profiled
Agilent Technologies Inc. | Codexis Inc. | Danaher Corporation | GenScript Biotech Corporation | Ginkgo Bioworks Holdings Inc. | Illumina Inc. | Merck KGaA | Novonesis A/S | Precigen Inc. | Synthego Corporation | Thermo Fisher Scientific Inc. | Twist Bioscience Corporation | Viridos Inc.
Market Segments Covered in the Synthetic Biology Market Report
By Product Outlook (Revenue, USD Billion, 2021-2034)
Enzymes | Synthetic DNA | Oligonucleotides | Cloning Kits | Chassis Organisms | Xeno-Nucleic Acids (XNAs)
By Technology Outlook (Revenue, USD Billion, 2021-2034)
PCR Technology | Genome Editing Technology | Next-Generation Sequencing | Bioinformatics & Computational Design | Laboratory Automation & Biofoundries
By Application Outlook (Revenue, USD Billion, 2021-2034)
Healthcare & Pharmaceuticals | Food & Agriculture | Industrial Biotechnology | Environmental Applications | Academic & Research Applications
By End User Outlook (Revenue, USD Billion, 2021-2034)
Biotechnology & Pharmaceutical Companies | Academic & Research Institutes | Industrial Biotechnology Companies | Contract Research Organizations (CROs) | Government & Public Research Organizations
By Regional Outlook (Revenue, USD Billion, 2021-2034)
North America (US, Canada) | Europe (Germany, France, UK, Italy, Spain, Netherlands, Russia, Rest of Europe) | Asia Pacific (China, Japan, India, Malaysia, South Korea, Indonesia, Australia, Vietnam, Rest of Asia Pacific) | Latin America (Mexico, Brazil, Argentina, Rest of Latin America) | Middle East & Africa (Saudi Arabia, UAE, Israel, South Africa, Rest of Middle East & Africa)
